Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-657-5 | CAS number: 67-51-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22nd February to 13th April 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 3,5-dimethylpyrazole
- EC Number:
- 200-657-5
- EC Name:
- 3,5-dimethylpyrazole
- Cas Number:
- 67-51-6
- Molecular formula:
- C5H8N2
- IUPAC Name:
- 3,5-dimethyl-1H-pyrazole
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Appearance: White crystalline powder.
Storage Conditions: Room temperature in the dark.
Date Received: 11th February 1994.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Olac Ltd., Bicester, Oxon, England.
- Age at study initiation: 4-7 weeks.
- Weight at study initiation: 96 to 119 g.
- Fasting period before study: Overnight prior to and approximately 4 hours after dosing.
- Housing: In treatment groups, up to 5 individuals of the same sex. In metal ages with wire mesh floors.
- Diet (e.g. ad libitum): Standard laboratory rodent diet, Biosure LAD 1, ad libitum except for fasting period.
- Water (e.g. ad libitum): Drinking water, ad libitum except for fasting period.
- Acclimation period: Minimum 7 days.
- Routine analysis was carried out on water and died.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): mean daily minimum and maximum 21 ºC and 22 ºC.
- Humidity (%): av. 47%.
- Air changes (per hr): 10 to 15 per hour.
- Photoperiod (hrs dark / hrs light): Artificial light between 0700 - 1900, in each 24 hour period
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Methycellulose.
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1% w/v aqueous methylcellulose.
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg - Doses:
- Preliminary Study - 500 mg/kg bw.
Main Test - Single dose of 1260, 1600 and 2000 mg/kg bw. - No. of animals per sex per dose:
- Preliminary Study: 2 males and 2 females.
Main Study: 5 males and 5 females at 2000 mg/kg bw. 5 females only at 1600 and 1200 mg/kg bw as these were determined as the most sensitive sex. - Control animals:
- no
- Details on study design:
- Preliminary Study:
- A single dose was administered.
Main Study:
- Males and females were initially exposed at 2000 mg/kg bw of the test material.
- Based on the response of the first dose, two further groups of female rats were dosed, to obtain a dose response curve and allow calculation of a lethal dose. A single dose was administered at 1260 and 1600 mg/kg bw.
Observations:
- Mortality, time of death was recorded.
- Clinical signs, observations were recorded soon after dosing and at frequent intervals on Day 1. Then for the remainder of the study observations were made twice daily. Nature and severity were recorded.
- Bodyweight, recorded on Days 1, 8 and 15 or at death. Individual weekly bodyweight changes and group mean bodyweights were calculated.
- Macroscopic examinations, necropsy was performed on Day 15. The cranial, abdominal and thoracic cavities were examined. - Statistics:
- Acute median lethal oral dose in females was calcualted using the Finney (1971) method.
Results and discussion
- Preliminary study:
- Results indicated that the LD50 > 500 mg/kg bw in females.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 717 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 360 - 2 269
- Mortality:
- Results from the preliminary study showed that the acutre lethal oral dose was greater than 500 mg/kg bw.
In the main study, all deaths occurred within the period ranging from 3 hours to 2 days post exposure.
The mortalities were as follows; two females at 1600 mg/kg bw and two males and four females at 2000 mg/kg bw. - Clinical signs:
- other: Piloerection, abnormal body carriage (hunched posture), lethargy, decreased respiratory rate, partially closed eyelids, pallor of the extremities, unsteadiness and increased lacrimation, abnormal gait (waddling), increased salivation, walking on toes, pro
- Gross pathology:
- A darkened appearance of the kidney cortex and spleen were observed in one female at 1600 mg/kg bw.
Thickening of the stomach walls and fluid contents in the stomach and intestines was observed in individuals at both 1600 and 2000 mg/kg bw. - Other findings:
- - Females were more sensitive than males.
- Recovery of surviving rats, judged on external appearance, occurred by Day 3 in the 1260 mg/kg bw group, Day 4 in the 1600 mg/kg bw group and Day 5 for the 2000 mg/kg bw group.
- No abnormalities were recorded in microscopic examinations.
Any other information on results incl. tables
Table 1. Time and Number of Deaths During the Main Study
Sex | Dose (mg/kg bw) | Number of deaths in a group of 5 | Day | ||||||||||
1 | 2 | 3 to 15 | |||||||||||
Hours after dosing | Observation | ||||||||||||
< 1/2 | 1 | 2 | 3 | 4 | 5 | 6 | 1st | 2nd | 1st | 2nd | |||
Male | 2000 | 2 | 2 | ||||||||||
Female | 1260 | 0 | |||||||||||
1600 | 2 | 1 | 1 | ||||||||||
2000 | 4 | 1 | 1 | 1 | 1 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 in female rats was determined, using the standard acute toxicity method, to be 1717 mg/kg bw.
- Executive summary:
In a GLP compliant study performed in accordance with the standardised guideline EU Method B.1, the acute oral toxicity of the test material was determined in female Sprague-Dawley rats following the standard acute method. Male and female rats were exposed to the test material via oral gavage, females were found to be more sensitive and were used in further testing to determine the LD₅₀. Under the conditions of the test the LD₅₀ was determined to be 1717 mg/kg bw.
According to Regulation (EC) 1272/2008 the test material requires classification as Acute oral toxicity category 4 "H302: Harmful if swallowed" with the signal word "Warning".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)